Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will Incyte's stock price increase by more than 20% by the end of 2024 following the FDA approval of Niktimvo?  | Binary | 3 | 4 months ago | ||
Will Incyte's Niktimvo be commercially available in the US by the end of 2024? | Binary | 2 | 4 months ago | ||
Will Incyte's Niktimvo receive approval from the EMA by mid-2025? | Binary | 2 | 4 months ago | ||
What will be the market share of Incyte's Niktimvo in the chronic GVHD treatment market by the end of 2025? | Categorical | 2 | 4 months ago | ||
Which company will be the primary competitor to Incyte's Niktimvo in the chronic GVHD market by the end of 2025? | Categorical | 2 | 4 months ago | ||
What will be the primary revenue source for Incyte in 2025? | Categorical | 2 | 4 months ago |